| 91 |
Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
Hye Won LeeHye Won Lee
KMSID: 1516079701 J Liver Cancer. 2022;22(2):91-92. Published online 2022 September 29 DOI: http://dx.doi.org/10.17998/jlc.2022.09.20 |
|
| 93 |
Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinomaCombination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun KimDong-Hyun Kim
KMSID: 1516079688 J Liver Cancer. 2022;22(2):93-102. Published online 2022 April 22 DOI: http://dx.doi.org/10.17998/jlc.2022.03.28 |
|
| 103 |
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinomaLiquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon KimEun-Ji Choi, Young-Joon Kim
KMSID: 1516079697 J Liver Cancer. 2022;22(2):103-114. Published online 2022 September 22 DOI: http://dx.doi.org/10.17998/jlc.2022.09.08 |
|
| 115 |
The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genesThe dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, Youngsic Jeon, Young Nyun ParkJeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, Youngsic Jeon, Young Nyun Park
KMSID: 1516079692 J Liver Cancer. 2022;22(2):115-124. Published online 2022 May 20 DOI: http://dx.doi.org/10.17998/jlc.2022.04.20 |
|
| 125 |
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatmentEffect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun KimYoung-Hwan Ahn, Heirim Lee, Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun Kim
KMSID: 1516079693 J Liver Cancer. 2022;22(2):125-135. Published online 2022 June 28 DOI: http://dx.doi.org/10.17998/jlc.2022.05.24 |
|
| 136 |
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational studyStereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jin-hong Park, Sang Min YoonJeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jin-hong Park, Sang Min Yoon
KMSID: 1516079695 J Liver Cancer. 2022;22(2):136-145. Published online 2022 September 16 DOI: http://dx.doi.org/10.17998/jlc.2022.08.18 |
|
| 146 |
Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional studyIndications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, Jae-Won JohSung Jun Jo, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh
KMSID: 1516079696 J Liver Cancer. 2022;22(2):146-157. Published online 2022 September 14 DOI: http://dx.doi.org/10.17998/jlc.2022.08.22 |
|
| 158 |
Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiologyClinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
Wonjoon Jang, Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young KimWonjoon Jang, Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
KMSID: 1516079699 J Liver Cancer. 2022;22(2):158-166. Published online 2022 September 27 DOI: http://dx.doi.org/10.17998/jlc.2022.09.18 |
|
| 167 |
The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysisThe diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
Young Chang, Soung Won Jeong, Jae Young Jang, Hyuksoo Eun, Young‑Sun Lee, Do Seon Song, Su Jong Yu, Sae Hwan Lee, Won Kim, Hyun Woong Lee, Sang Gyune Kim, Seongho Ryu, Suyeon ParkYoung Chang, Soung Won Jeong, Jae Young Jang, Hyuksoo Eun, Young‑Sun Lee, Do Seon Song, Su Jong Yu, Sae Hwan Lee, Won Kim, Hyun Woong Lee, Sang Gyune Kim, Seongho Ryu, Suyeon Park
KMSID: 1516079700 J Liver Cancer. 2022;22(2):167-177. Published online 2022 September 29 DOI: http://dx.doi.org/10.17998/jlc.2022.09.19 |
|
| 178 |
Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case reportFibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
Seong Kyun NaSeong Kyun Na
KMSID: 1516079691 J Liver Cancer. 2022;22(2):178-182. Published online 2022 June 22 DOI: http://dx.doi.org/10.17998/jlc.2022.06.10 |
|
| 183 |
Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case reportNovel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report
Sung Hoon Chang, Tae Suk Kim, Yong Hwan Jeon, Nuri Hyun Jung, Dae Hee ChoiSung Hoon Chang, Tae Suk Kim, Yong Hwan Jeon, Nuri Hyun Jung, Dae Hee Choi
KMSID: 1516079690 J Liver Cancer. 2022;22(2):183-187. Published online 2022 August 24 DOI: http://dx.doi.org/10.17998/jlc.2022.08.03 |
|
| 188 |
Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case reportHepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
Moon Haeng Hur, Haeryoung Kim, Jeong-Hoon LeeMoon Haeng Hur, Haeryoung Kim, Jeong-Hoon Lee
KMSID: 1516079689 J Liver Cancer. 2022;22(2):188-193. Published online 2022 August 31 DOI: http://dx.doi.org/10.17998/jlc.2022.08.17 |
|
| 194 |
Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case reportHepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
Choong Hee Kim, Gwang Hyeon Choi, Hee Young Na, Chang Jin Yoon, Jai Young Cho, Sangmi Jang, Ji Hye Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang JeongChoong Hee Kim, Gwang Hyeon Choi, Hee Young Na, Chang Jin Yoon, Jai Young Cho, Sangmi Jang, Ji Hye Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
KMSID: 1516079694 J Liver Cancer. 2022;22(2):194-201. Published online 2022 September 15 DOI: http://dx.doi.org/10.17998/jlc.2022.08.24 |
|
| 202 |
Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case reportMultidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report
Sangmi Kim, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo SungSangmi Kim, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
KMSID: 1516079698 J Liver Cancer. 2022;22(2):202-206. Published online 2022 September 20 DOI: http://dx.doi.org/10.17998/jlc.2022.09.17 |
|
| 207 |
Yoon et al. Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer RegistryYoon et al. Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
Jeong-Hoon LeeJeong-Hoon Lee
KMSID: 1516079702 J Liver Cancer. 2022;22(2):207-207. Published online 2022 June 8 DOI: http://dx.doi.org/10.17998/jlc.21.1.58.e1 |
|
